HELE / Helen of Troy and NanoString Technologies Trade Set-ups

Helen of Troy's (HELE) second-quarter fiscal 2024 results reflect a decline in earnings and sales due to lower consumer demand for certain product cat more_horizontal

Revenue and profits continue to fall at Helen of Troy. The health and beauty segment has been especially weak. more_horizontal

Helen of Troy Limited (NASDAQ:HELE ) Q2 2024 Earnings Call Transcript October 4, 2023 9:00 AM ET Company Participants Jack Jancin - SVP, Corporate Bus more_horizontal

Helen of Troy (HELE) came out with quarterly earnings of $1.74 per share, beating the Zacks Consensus Estimate of $1.60 per share. This compares to ea more_horizontal

Helen of Troy (NASDAQ:HELE) is expected to report lower revenue and earnings for the second quarter of its financial year when it reports back to inv more_horizontal

Helen of Troy's (HELE) second-quarter performance is likely to reflect pressure on some product categories amid lower demand and changes in buying pat more_horizontal

Helen of Troy Limited's M&A strategy backfired, leading to a decline in sales and earnings and the resignation of the CFO. The company is a collection more_horizontal

Here is how Helen of Troy (HELE) and Ingredion (INGR) have performed compared to their sector so far this year. more_horizontal